FindTrial
Sign In

Comprehensive study for surgical effect and prognosis of pulmonary atresia, ventricular septal defect, and major aortopulmonary collateral arteries

A single-center ambispective cohort study for surgical effect and prognostic factors of pulmonary atresia, ventricular septal defect, and major aortopulmonary collateral arteries

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033401
Enrollment
Unknown
Registered
2020-05-31
Start date
2020-06-05
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major aortopulmonary collateral arteries

Interventions

selective UF:selective unifocalization

Sponsors

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Ptients are primarily diagnosed with PA/VSD/MAPCAs patients from June 2017 to December 2030; 2. Patients or their guardians agreed to participate in this study. .

Exclusion criteria

Exclusion criteria: 1. PA/VSD/MAPCAs complicated with other severe intracardiac malformations, such as complete anomalous pulmonary venous drainage, complete endocardial cushion defect, pulmonary vein stenosis, etc. 2. Patients and guardians are not willing to participate in this study.

Design outcomes

Primary

MeasureTime frame
death;reintervention;pRV/pAo;—

Countries

China

Contacts

Public ContactQiang Wang

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

wq.cory@163.com+86 15699870837

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026